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Abstract
Alzheimer’s disease, a debilitating neurodegenerative illness, is caused by the irreversible
aggregation of beta-amyloid proteins in the brain. In Alzheimer’s brains, the protein can become
disfigured, causing it to aggregate into long, insoluble fibers that deposit on brain tissue.
Studying the aggregation mechanisms of amyloid proteins can lead to a deeper understanding of
the progression of Alzheimer’s disease and possibly point towards a potential cure or treatment
for the disease. Heat induced aggregation of insulin provides a model system to study the
aggregation of amyloidogenic proteins. This study investigates the early stages of heat induced
insulin aggregation using dynamic light scattering in order to assess the aggregation mechanism
and the potential for reversal by thermal quenching to room temperature. In order to accomplish
this, samples of insulin solution were heated for specific incubation intervals and monitored
using dynamic light scattering in the time after removal from heat to study the behavior of
insulin after quenching to room temperature. Results indicate that large protein aggregates form
after sufficient time at heat, but quenching to room temperature can cause them to dissociate.
However, the initial stage in the aggregation mechanism is shown to be an irreversible
transformation from monomer to dimer.
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Introduction
Alzheimer’s disease is an irreversible neurodegenerative disease that slowly attacks
memory and degrades brain function (1). The disease affects primarily older patients and is the
most common cause of dementia among older people (1). According to the Alzheimer’s
Association, one in eight older Americans – a population totaling 5.4 million - are living with
Alzheimer’s disease (2). It is the sixth-leading cause of death in the United States (2). Some
medications can help lessen symptoms such as memory loss and confusion, but unlike the other
top ten causes of death in the United States, there is currently no way to cure, prevent, or slow
the progression of Alzheimer’s disease (3) (4). Thus, there is an urgent need to understand the
cause of and find a cure for Alzheimer’s disease.
The appearance of long, insoluble protein deposits on brain tissue is a common
characteristic of many neurodegenerative diseases, including Alzheimer’s disease (5). The
deposits, called plaques and tangles, are found between and around neurons in Alzheimer’s
disease patients’ brains (2). These buildups are made up of beta-amyloid proteins that are
produced from amyloid precursor protein (APP) in the fatty membrane surrounding nerve cells (6)
(7)

. APP can be found in healthy brains as a precursor for other proteins that promote neuronal

growth and survival. However, by an alternative pathway, APP forms beta-amyloid peptides that
become disfigured, causing the formation of fibril aggregates with other beta-amyloid peptides.
It is presumed that specific sizes of beta-amyloid aggregates in block cell communication and
disrupt processes that normal cells need to survive (2). It has been shown that mice injected with
beta-amyloid fibril “building blocks” develop symptoms characteristic of Alzheimer’s disease (8).
The continued growth of these smaller aggregates leads to the production of plaques on brain
tissue (7). In order to prevent or cure Alzheimer’s disease, it is important to understand the
aggregation mechanism and the potential for aggregation-reversal of the beta-amyloid peptide.
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Historically, much work has been performed on the properties and aggregation of
amyloid proteins, including the beta-amyloid peptide. It is currently believed that the aggregation
of beta-amyloids is caused by a partial unfolding of the protein. The protein undergoes a coil-toβ-sheet transition and subsequently self-associates due in part to the exposure of hydrophobic
regions within the tertiary structure. It is believed that the subsequently formed oligomers and
protofibrils are the building blocks for mature, insoluble fibrils (6).
It has been found that amyloid proteins exhibit similar aggregation behaviors that can be
caused by a number of factors such as pH and elevated solution temperature. These two in
particular have been the classical methods of inducing amyloid aggregation (9). Human insulin,
for example, is a classic amyloidogenic protein that aggregates at high temperature (> 60ºC) in
acidic solution (pH = 1.6). After sufficient exposure to high temperatures, insulin in acidic
solution will form long, insoluble fibers. The absorbance intensity of aggregating insulin exhibits
a sigmoidal curve, increasing as aggregation progresses. Initially, the intensity increase is slow,
but this is followed by a rapid increase as the insulin aggregates into fibrils. After this rapid fibril
formation, the growth saturates, and the rate of intensity increase becomes zero. Many studies
have shown that protein fibers eventually form at the end of the annealing process (9). It is known
that the formation of amyloid protein fibers is irreversible, although it is unclear at what point
irreversibility is attained. Since insulin is relatively inexpensive, readily available, and exhibits a
similar molecular and fibril structure to beta-amyloids, it is an ideal model system to study betaamyloid aggregation (10) (11) (12). By studying the amyloid aggregation in this model system we can
gain a better understanding of the cause of – and a possible mechanism to inhibit or cure – the
underlying causes of Alzheimer’s disease.
Insulin heat precipitation does not significantly alter the natural structure of the
molecules, thus making it an ideal way to analyze the aggregation process. The aggregation itself
4

is a process understood to be comprised of three reactions. The first is nucleation, the slowest of
the three, involving the simultaneous interaction of three to four insulin monomers. The second
reaction is the growth of the nucleus into fibrils and the third is the formation of large precipitate
groups. The large precipitate groups are generally irreversibly insoluble without major changes
in solution characteristics (9). A proposed mechanism of insulin fibrillation is diagramed in Figure
1, though the actual mechanism is still under investigation (10).

Figure 1: A proposed mechanism of insulin aggregation (10).

Preliminary kinetic studies using dynamic light scattering (DLS) were performed on
insulin in acidic solution (pH = 1.6) at 2 mg/ml. It is known that the scattering intensity is
proportional to the size of the aggregates at a constant concentration. Figure 2 shows the
scattering intensity variation (scattering angle = 90º) of insulin aggregation at 60ºC as a function
of annealing time. As previously mentioned the data follows a sigmoidal curve, though only the
initial portion is shown. The early stage (< 140 min) of the aggregation indicated an incremental
increase in scattering intensity. A sudden increase in scattering intensity was observed after
approximately 150 minutes and beyond this point the average scattering intensity fluctuates
drastically due to many intensity spikes recorded over the data collection time, indicative of the
formation of large and non-uniform aggregates. These results point towards an early aggregation
stage that takes place by a step-by-step process until a certain point is reached and the fibrillation
becomes rapid.
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Figure 2: (a) The scattering intensity at 90° of human insulin at 60°C as a function of annealing time. For better
resolution, the enlarged plot of the early stage aggregation of the insulin (in red box) is shown in (b).

Figure 2 makes apparent the initially-slow heat induced aggregation of insulin. This study
assumes that irreversibility by thermal quenching – removal from heat to a room temperature
environment – is attained very early in the aggregation process, before fibrils are formed and
insulin aggregates become insoluble. Thus, the area of interest on the sigmoidal curve is early,
before rapid aggregation begins. The earliest portion of this slow stage will be investigated to
assess the potential reversibility of aggregation by thermal quenching. It is hypothesized that
irreversibility is attained at heating times between 10 and 20 minutes. The goal of this study is to
find that point of irreversibility and show that before that point is reached, reversal of insulin
aggregation can be performed.
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Experimental Procedure
Materials
Human insulin was provided by Professor Georges Belford and his group at Rensselaer
Polytechnic Institute. All reagents and chemicals are analytical grade.

Sample Preparation
Solutions of human insulin in concentrations of 20 mg/ml are made by dissolving 40 mg
insulin in 2 ml of a previously prepared “insulin solvent” of 100 mM NaCl and 25 mM HCl of
pH 1.6. The solutions are titrated to basicity with 1M NaOH. Insulin is not soluble near its pI of
5.6 and comes out of solution. NaOH addition is stopped once the solution becomes sufficiently
basic for the insulin to redissolve. The solutions are then back-titrated using the insulin solvent,
again just past the point of insulin redissolution. After titration, two solutions (up until this point
prepared in parallel) are combined, diluted to 8 mg/ml using the insulin solvent, and adjusted to a
pH of 1.6 with 1M HCl using a Thermo brand pH meter. Dust and large particle contaminants
are removed by filtering the solutions through 0.2 μm hydrophilic filters at multiple stages of the
process, including before the sample pH cycle titrations and after the pH adjustment to 1.6. The
samples are divided into light scattering cuvettes, with approximately 1 ml of insulin solution in
each. The cuvettes are sealed and the samples are checked for uniformity of size (~2.2 nm
hydrodynamic radius for monomeric insulin) using dynamic light scattering. The samples are
stored in a refrigerator to suppress unwanted protein activity.
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Sample Heating
Aggregation is induced by placing the glass cuvettes into a dry heat block, set on Low,
Power Level 9 for a measured temperature of 65˚C. The amount of time required for a 1 ml
sample in a glass DLS cuvette to reach 65˚C, the incubation temperature, is dependent on the
sample position in the heat block. A temperature map of the heat block was created, shown in
Figure 3. The well that was selected for use is marked by an asterisk. In this well, approximately
seven minutes are required for the sample to reach the incubation temperature.
The samples are allowed this warm up time to reach 65˚C and then further incubated for
set intervals of time. An example heating schedule is shown in Figure 4, where the sample is
warmed, incubated, and removed from heat. Immediately after removal from heat, the samples
are measured by DLS. This entire process is performed on one sample at a time in order to
ensure uniformity in heating and measurement.

Figure 3: Heat block map. (a) Thermometer well. (b) Sample well. The well used for sample heating is denoted by
an asterisk and was chosen based on the proximity to the thermometer and the minimal time taken to reach 65°C.
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Figure 4: Example sample heating history. The red diamonds indicate DLS measurements (initial measurement not
shown). The dotted black line represents unknown temperature decrease back to room temperature.

Dynamic Light Scattering
The quality of prepared insulin samples and the assessment of their aggregation is
performed using dynamic light scattering (DLS). DLS is a powerful analytical method for
determining the hydrodynamic radius of particles in solution. The instrument itself is an ALV
Compact Goniometer System (CGS-3MD), consisting of a 22mW He-Ne laser that emits
vertically polarized light at a wavelength of 632.8 nm and four avalanche photo diode (APD)
detectors that collect the intensity of the scattered light (13) (14). For this study, single detector
mode was used with a scattering angle (θ) of 90°.
When the laser light hits particles in solution, it scatters in all directions due to Rayleigh
scattering. Because the laser is monochromatic and coherent, the detector observes a timedependent fluctuation in intensity due to the Brownian motion of the particles in solution. This
variable intensity is collected by the detectors and an autocorrelation function is generated to
relate the delay time, τ and scattering intensity, I. The autocorrelation function is generated by an
ALV-7004 digital multiple tau real time correlator and expressed as Equation 1.
9

∞

𝐺(𝜏) = ∫0 𝐼(𝑡)𝐼(𝑡 + 𝜏)𝑑𝑡

(Equation 1)

In Equation 2, time delay, τ, refers to an arbitrary amount of time after the intensity
measurement was taken (time = t). As τ grows larger, G(τ) exhibits an exponential decay as the
correlation between the initial state and final state scattering intensities deteriorates. This
relationship preserves the dynamic information of the particles in solution. Additionally, it has
the ability to reflect system polydispersity, because populations of different sizes exhibit
different decay times. Multiple decays can be shown within one autocorrelation function. Further
experimental conditions are considered in a relationship expressing G(τ) in terms of the field
autocorrelation function, g(τ), generated from the Siegert relation.
𝐺(𝜏) = 1 + 𝛾𝑔(𝜏)2

(Equation 2)

Here, γ is the instrumental coherence factor. The field autocorrelation function, g(τ),
represents the time decay of the position autocorrelation function of the particles. For a
polydisperse system, g(τ) can be expressed as follows.
𝑔(𝜏) = ∑𝑖 𝐴𝑖 𝑒 −𝐷𝑖 𝑞
where: 𝑞 =

4𝑛𝜋
𝜆

2𝜏

𝜃

𝑠𝑖𝑛 2

(Equation 3)
(Equation 4)

In this expression, q is the scattering vector and Ai represents the light scattering
amplitude of the particle i with diffusion coefficient Di (14). For solutions made up of spherical,
non-interacting particles undergoing Brownian motion, the Stokes-Einstein equation relates the
particle radius, Ri, and the diffusion coefficient, Di.
𝑘𝑇

𝐷𝑖 = 6𝜋𝜂

𝑤 𝑅𝑖

(Equation 5)

Here, k, T, and ηw are the Boltzmann constant, absolute temperature, and the viscosity,
respectively. In this case, the viscosity is that of water (the solvent). The geometry of aggregating
insulin is not spherical, so Ri is replaced in Eq. 1 by RHi, an equivalent hydrodynamic radius.
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Thus, the size of particles in solution is obtained. The ALV software analyzes the generated
autocorrelation function using CONTIN procedure. The algorithm is ideal for polydisperse and
multimodal systems – for instance, a solution of aggregating insulin with particle populations of
different sizes (15) (16).
The insulin samples are analyzed with DLS before and after heating, allowing for
detailed analysis of particles in the solution. Three to five measurements at room temperature
lasting 60 seconds each are taken immediately after the samples are removed from heat. Identical
sets of measurements are repeated again 30 and/or 60 minutes after removal from heat, once the
samples have been allowed to rest at room temperature, and additionally 24+ hours after heating.
The scattering intensity, autocorrelation function, and particle size distribution data are collected
and analyzed over all measurement points in order to observe the insulin aggregation after
removal from heat.

Data Analysis
The ALV700X software outputs data in multiple forms. Most of this data is interpretable
as produced, but some, namely the size distribution data of the particles in solution, needs
additional work in order to generate quantifiable figures. Custom MATLAB code was written in
order to analyze this data. The code intakes Excel files filled with peak distribution data points.
Iterating over data sets for all measured samples, it calculates peak width by identifying the
maximum point on the distribution peak (which is equal to, by definition, 1) and then the
derivative as it moves to the next point on left of the peak. It repeats this process until the
derivative is null, at which point the program has reached the left boundary of the peak. This
point is saved, the process is repeated to the right of the peak. The difference of the two saved
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points is calculated as the peak width. The program records all data back into the Excel sheet
from which it was originally read.
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Results and Discussion
As described previously, ALV700X software produces data in the forms of the measured
scattering intensity, the generated autocorrelation function, and the hydrodynamic radius
distribution. A preliminary study, different from the one proposed in the Sample Heating section,
was carried out before the development of the aforementioned procedure using identical insulin
samples. The details and results of this study and the formal procedure are described below.

Preliminary results
Initial studies on solutions of insulin revealed the possibility of reversal by thermal
quenching. Samples of insulin were heated for increments of 5 minutes, allowed to equilibrate to
room temperature, and monitored with DLS. The most telling result of this preliminary study
was the measured scattering intensity, which is proportional to the particle size when the
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Figure 5: Insulin scattering intensity measurements taken after (a) one, and (b) two 5-minute heating periods
(totaling 5 and 10 minutes at heat, respectively). The multiple lines represent repeated measurements.
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After one 5-minute increment of heating and equilibration to room temperature, the
average scattering intensity was equal to that of the initial measurement at 35 kHz. No intensity
change was realized. After two 5-minute heating increments, totaling 10 minutes of heating, a
slight increase in average scattering intensity was realized, but no substantial change was
present. The results are visible in Figure 5, which shows the intensity measurements versus the
measurement time.
However, after three 5-minute heating increments, a new phenomenon was realized.
After equilibration to room temperature, the first measurements taken with DLS showed spikes
in intensity. Intensity spikes are indicative of large particles diffusing into and out of the laser
light. Because the solutions are sealed, these large particles must be formations of insulin
aggregates. However, these spikes were not repeated in subsequent measurements. Figure 6
shows two of the measurements taken after three 5-minute heating periods.
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Figure 6: Insulin scattering intensity measurements taken after three 5-minute heating increments, totaling 15
minutes at heat. The blue line is first measurement taken after equilibration to room temperature.

The phenomenon witnessed in Figure 5 was repeated after heating for an additional 5-minute
increment. The total time spent on heat is now 20 minutes. After equilibration to room
14

temperature, even more intensity spikes were present. Again, these spikes decay into a relatively
flat intensity baseline. Figure 7 shows the measurements taken after four 5-minute heating
periods.
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Figure 7: Insulin scattering intensity measurements taken after four 5-minute heating increments, totaling 20
minutes at heat. The blue line is first measurement taken after equilibration to room temperature; red, the second,
and green, later.

The presence of intensity spikes is indicative of large particles forming in solution after
heating. These aggregates dissociate after time spent at room temperature. However, it is
important to note that the intensity baseline that is realized in Figures 6 and 7 is not equal to the
initial intensity baseline of 35 kHz; it is slightly higher (around 38 kHz after 20 minutes at heat).
Although the large particles that cause the intensity spikes are disappearing, some permanent
aggregation is present.

Study results
The preliminary study showed that the larger aggregates formed after heating will
dissociate after thermal quenching to room temperature. The study described in the Sample
Heating section above aims to assess the nature of these supposedly permanent aggregates and
15

assess the reversibility of aggregation induced with shorter heating times. Based on the
aforementioned preliminary results, identical solutions of insulin were heated for 10, 15, 25, and
29 minutes in order to assess even earlier stages in the aggregation process. The autocorrelation
functions, hydrodynamic radius peak distributions and widths, and scattering intensity
measurements for those samples are discussed below.
The autocorrelation functions for the heated samples are shown below in Figure 8. They
show the average autocorrelation functions generated at specified times after the samples are
removed from heat. The autocorrelation function, as discussed earlier, represents the decay in
signal as lag time grows. If two distinct particle size populations were present at the time of a
single measurement, the functions would show two decays. If population size was relatively
uniform but changing over time, for instance during the time after heating, the functions would
decay more slowly, reaching zero at larger and larger lag times.
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Figure 8: Autocorrelation functions at various times after removal from heat for samples heated (a) 10, (b) 15, (c)
25, and (d) 29 minutes, respectively.

As shown, the functions show near-identical decays, with the exception of some of the
measurements taken immediately after removal from heat, likely an artifact of temperature
gradient between the warm solution and room temperature instrument. This result lends one to
conclude that not much aggregates during the studied period. This is confirmed by the derived
particle size distributions, calculated as described previously. Figure 9 shows the averaged size
distributions and mean particle sizes as a function of time after removal from heat.
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Figure 9: Hydrodynamic radii peak distributions and mean particle sizes for samples heated (a) 10, (b) 15, (c) 25,
and (d) 29 minutes, respectively.
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The figures above show very little statistical difference in the time after heating,
regardless of heat time, indicating that the majority of the population is still in monomeric form.
However, the peak distributions are much clearly different after heating for all trials. The peaks
exhibit broadening as a small fraction of the population becomes slightly larger, enough to skew
the peak without generating a new distribution. This is thought to be the formation of dimers
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from monomers. The widths of the peaks are quantified and plotted below in Figure 10.
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Figure 10: Calculated hydrodynamic radius peak distribution widths versus time after removal from heat for
samples heated (a) 10, (b) 15, (c) 25, and (d) 29 minutes, respectively
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The high standard deviations in Figure 6 are likely due to the fact that at any given time,
particles are diffusing into and out of the laser light. The averages taken in order to form the
above plots group measurements of 60 seconds across times as different as 8-10 minutes,
meaning it is likely that many different particles are present for each measurement. Given the
small amount of particles that are actually aggregating, this can have a substantial effect on the
hydrodynamic radius calculation.
The samples heated for 10 minutes show an average peak broadening that is not
statistically significant. Samples heated for 15 minutes show a similar trend with slightly more
statistical significance, and samples heated for 25 and 29 minutes show statistically significant
broadening. Because the absolute peak width values can vary between samples, it is best to
compare their changes after heating. Figure 11 shows the relative broadening after the samples
were removed from heat.
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Figure 11: Peak broadening versus time after removal from heat for all samples

In all samples, the broadening does not significantly decrease at any point after removal
from heat. This indicates that the formed dimers do not return to monomers by thermal
quenching. This conclusion is supported by not only the peak distribution data in Figure 8 but
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also by the scattering intensity measurements from each sample. As previously mentioned, the
scattering intensity is proportional to the size of the dissolved particles when concentration is
kept constant. This assumption is valid for this system because since only a small amount of the
particles are aggregating, the concentration can be assumed unchanged. The intensity
measurements for the samples are shown below in Figure 12.
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Figure 12: Scattering intensity data versus time after removal from heat for samples heated (a) 10, (b) 15, (c) 25,
and (d) 29 minutes, respectively
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Like the peak width, in order to compare the samples it is best to look at the relative
change in intensity versus time due to the variable nature of the absolute measurement. Figure 13
shows the increase in intensity from the initial preheat baseline plotted against time after removal
from heat.
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Figure 13: Intensity increase from preheat baseline versus time after removal from heat.

Like the peak width, the intensity does not decrease over time after removal from heat,
indicating that the cause of the intensity increase is still present. As previously mentioned, it is
thought that the increase is caused by a small amount of dimer in solution. As expected, the
samples display an intensity increase relative to the time spent on heat, i.e. the sample that was
heated the longest displays the largest intensity gain, etc.

22

Conclusions and Future Work
From the experiments performed in this study, it is clear that even just 10 minutes of
heating produces aggregation that is irreversible by thermal quenching. The aggregation is most
likely from monomer to dimer and only for a tiny portion of the particles in solution. Due to the
nature of this aggregation, it is apparent that the studied realm is still in the slow initial realm of
the sigmoidal aggregation curve. This is in contrast with the formation of larger aggregates that
produce significant spikes in scattering intensity, which disappear after thermal quenching to
room temperature. Proposed mechanisms of insulin aggregation suggest a slow and potentially
reversible nucleation step. The initial step in the heat induced aggregation of insulin is shown to
be different.
There is much potential for the continuation of this project. Of course, similar studies can
be performed on insulin samples heated for shorter times; for instance 2, 5, 7, and 10 minutes.
Because this heat times in this study were too long, despite the small amount of aggregation
attained, shorter heat times will yield different and potentially more favorable reversibility
results. However, according to the results of this study, it is likely that once any dimerization
occurs, the formed aggregate is permanent, despite the shorter length of heating.
Additionally, the University of Connecticut Institute of Materials Science recently
purchased a Bruker Small Angle X-Ray Scattering (SAXS) instrument. SAXS added capabilities
over DLS, including the ability to distinguish morphology. Where DLS does not take into
account shape when determining hydrodynamic radius, SAXS can actually produce information
about particle shapes. This is particularly valuable for this study because the morphology of the
insulin is changing as it aggregates. This analysis could yield critical information about the
specific mechanisms of amyloid aggregation and potential for reversibility.
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